002173 创新医疗
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-0.861-1.817-3.783-5.021-13.640
总资产报酬率 ROA (%)-0.709-1.484-3.007-3.963-11.142
投入资产回报率 ROIC (%)-0.803-1.691-3.430-4.500-13.149

边际利润分析
销售毛利率 (%)11.78911.4464.3106.7363.843
营业利润率 (%)-3.582-3.183-11.075-7.923-29.958
息税前利润/营业总收入 (%)-4.614-5.917-12.053-15.341-39.193
净利润/营业总收入 (%)-3.893-4.256-10.370-14.526-43.411

收益指标分析
经营活动净收益/利润总额(%)60.08865.472112.33472.40237.468
价值变动净收益/利润总额(%)5.5695.257-4.524-15.363-5.584
营业外收支净额/利润总额(%)2.92726.670-4.41045.31523.858

偿债能力分析
流动比率 (X)2.3392.2532.3942.7173.125
速动比率 (X)2.2242.1242.2412.5933.029
资产负债率 (%)17.28017.98818.57722.21619.910
带息债务/全部投入资本 (%)3.3632.3751.8231.377--
股东权益/带息债务 (%)2,774.2803,931.3775,086.9346,445.1843,520.866
股东权益/负债合计 (%)478.428455.706438.085349.924402.067
利息保障倍数 (X)4.9903.7538.33617.972-257.956

营运能力分析
应收账款周转天数 (天)50.06034.49934.21939.5200.000
存货周转天数 (天)19.48322.97624.46321.0290.000